These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 18710424

  • 1. Increased hepatic expression is a major determinant of serum alanine aminotransferase elevation in mice with nonalcoholic steatohepatitis.
    Liu R, Pan X, Whitington PF.
    Liver Int; 2009 Mar; 29(3):337-43. PubMed ID: 18710424
    [Abstract] [Full Text] [Related]

  • 2. Isoform-specific alanine aminotransferase measurement can distinguish hepatic from extrahepatic injury in humans.
    Rafter I, Gråberg T, Kotronen A, Strömmer L, Mattson CM, Kim RW, Ehrenborg E, Andersson HB, Yki-Järvinen H, Schuppe-Koistinen I, Ekblom B, Cotgreave I, Glinghammar B.
    Int J Mol Med; 2012 Nov; 30(5):1241-9. PubMed ID: 22922605
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [Abstract] [Full Text] [Related]

  • 4. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM.
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [Abstract] [Full Text] [Related]

  • 5. Murine alanine aminotransferase: cDNA cloning, functional expression, and differential gene regulation in mouse fatty liver.
    Jadhao SB, Yang RZ, Lin Q, Hu H, Anania FA, Shuldiner AR, Gong DW.
    Hepatology; 2004 May; 39(5):1297-302. PubMed ID: 15122758
    [Abstract] [Full Text] [Related]

  • 6. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.
    Nan YM, Wu WJ, Fu N, Liang BL, Wang RQ, Li LX, Zhao SX, Zhao JM, Yu J.
    Scand J Gastroenterol; 2009 May; 44(9):1121-31. PubMed ID: 19606393
    [Abstract] [Full Text] [Related]

  • 7. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC.
    J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
    [Abstract] [Full Text] [Related]

  • 8. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R, Clarkson V, Verdonk RC, Marais AD, Shephard EG, Ryffel B, de la M Hall P.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [Abstract] [Full Text] [Related]

  • 9. Alanine aminotransferase isoenzymes: molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity.
    Yang RZ, Park S, Reagan WJ, Goldstein R, Zhong S, Lawton M, Rajamohan F, Qian K, Liu L, Gong DW.
    Hepatology; 2009 Feb; 49(2):598-607. PubMed ID: 19085960
    [Abstract] [Full Text] [Related]

  • 10. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
    Yamazaki Y, Kakizaki S, Horiguchi N, Sohara N, Sato K, Takagi H, Mori M, Negishi M.
    Gut; 2007 Apr; 56(4):565-74. PubMed ID: 16950832
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM.
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [Abstract] [Full Text] [Related]

  • 12. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK.
    Life Sci; 2012 Jan 30; 90(5-6):200-5. PubMed ID: 22154902
    [Abstract] [Full Text] [Related]

  • 13. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov 30; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 14. Determination of enzymatic source of alanine aminotransferase activity in serum from dogs with liver injury.
    Miyazaki M, Rosenblum JS, Kasahara Y, Nakagawa I, Patricelli MP.
    J Pharmacol Toxicol Methods; 2009 Nov 30; 60(3):307-15. PubMed ID: 19748590
    [Abstract] [Full Text] [Related]

  • 15. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium.
    Sahai A, Pan X, Paul R, Malladi P, Kohli R, Whitington PF.
    Am J Physiol Gastrointest Liver Physiol; 2006 Jul 30; 291(1):G55-62. PubMed ID: 16439472
    [Abstract] [Full Text] [Related]

  • 16. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
    Pathil A, Mueller J, Warth A, Chamulitrat W, Stremmel W.
    Hepatology; 2012 May 30; 55(5):1369-78. PubMed ID: 22183915
    [Abstract] [Full Text] [Related]

  • 17. Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis.
    Salamone F, Galvano F, Marino Gammazza A, Paternostro C, Tibullo D, Bucchieri F, Mangiameli A, Parola M, Bugianesi E, Li Volti G.
    Dig Liver Dis; 2012 Apr 30; 44(4):334-42. PubMed ID: 22197629
    [Abstract] [Full Text] [Related]

  • 18. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM.
    Hepatology; 2009 Nov 30; 50(5):1421-30. PubMed ID: 19676126
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic significance of alanine aminotransferase isoenzymes in alcoholic and non-alcoholic fatty liver cancers.
    Zhou D, Yuan Z, Shu X, Tang H, Li J, Ye Y, Tao N, Zhou F, Zhang J, Zheng J, Wu Q, Zhang J.
    Biosci Rep; 2023 Nov 30; 43(11):. PubMed ID: 37883219
    [Abstract] [Full Text] [Related]

  • 20. [The role of Fas mutation on non-alcoholic steatohepatitis in mice].
    Su SS, Han F, Wang RQ, Ren WG, Wu WJ, Kong LB, Zhao SX, Nan YM.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep 30; 19(9):653-7. PubMed ID: 22152378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.